Principal Financial Group
IMCR icon

Principal Financial Group’s Immunocore IMCR Stock Holding History

Principal Financial Group’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.4M Sell
485,789
-33,341
-6% -$986K 0.01% 1168
2026
Q1 		$15.7M Sell
519,130
-139,306
-21% -$4.51M 0.01% 1066
2025
Q4 		$22.9M Buy
658,436
+247,027
+60% +$8.72M 0.01% 813
2025
Q3 		$14.9M Sell
411,409
-43,510
-10% -$1.48M 0.01% 1033
2025
Q2 		$14.3M Sell
454,919
-23,945
-5% -$744K 0.01% 1052
2025
Q1 		$14.2M Sell
478,864
-23,993
-5% -$720K 0.01% 1055
2024
Q4 		$14.8M Sell
502,857
-43,461
-8% -$1.37M 0.01% 1054
2024
Q3 		$17M Buy
546,318
+109,206
+25% +$3.97M 0.01% 940
2024
Q2 		$14.8M Sell
437,112
-80,092
-15% -$4.08M 0.01% 1044
2024
Q1 		$33.6M Buy
517,204
+33,868
+7% +$2.32M 0.02% 627
2023
Q4 		$33M Sell
483,336
-2,550
-0.5% -$133K 0.02% 593
2023
Q3 		$25.2M Buy
485,886
+2,129
+0.4% +$126K 0.02% 686
2023
Q2 		$29M Buy
483,757
+29,953
+7% +$1.71M 0.02% 637
2023
Q1 		$22.4M Sell
453,804
-48,179
-10% -$2.71M 0.02% 780
2022
Q4 		$28.6M Sell
501,983
-24,269
-5% -$1.37M 0.02% 620
2022
Q3 		$24.7M Buy
526,252
+226,302
+75% +$10.8M 0.02% 646
2022
Q2 		$11.2M Buy
299,950
+64,405
+27% +$2.09M 0.01% 1190
2022
Q1 		$7.04M Buy
235,545
+1,106
+0.5% +$27.9K ﹤0.01% 1524
2021
Q4 		$8.03M Buy
234,439
+49,514
+27% +$1.79M ﹤0.01% 1504
2021
Q3 		$6.86M Buy
184,925
+7,820
+4% +$264K ﹤0.01% 1568
2021
Q2 		$6.92M Buy
177,105
+53,533
+43% +$2.07M ﹤0.01% 1609
2021
Q1 		$5.26M Buy
+123,572
New +$5.5M ﹤0.01% 1652

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Principal Financial Group's IMCR Position: Q2 2026 in Review

Principal Financial Group reduced its Immunocore (IMCR) stake by 6.4% in Q2 2026, selling an estimated $986K and leaving 485,789 shares worth $15.4M. The position accounts for 0.01% of the portfolio, ranked #1168.

Principal Financial Group first reported a position in IMCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $33.6M in Q1 2024. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Principal Financial Group held 485,789 shares of Immunocore worth $15.4M as of Q2 2026.
  • Principal Financial Group sold 33,341 Immunocore shares in Q2 2026, an estimated $986K.
  • Immunocore made up 0.01% of Principal Financial Group's portfolio in Q2 2026, its #1168 holding.
  • Principal Financial Group first reported a position in Immunocore in Q1 2021 and has held it in 22 quarters since.
  • Principal Financial Group's Immunocore position peaked at $33.6M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.